NEW YORK (GenomeWeb News) – The National Institutes of Health is putting $24 million this year into a new program that will attempt to develop drugs for rare diseases that may affect millions of Americans for which there are no treatments or cures, and for 'neglected' diseases around the world that frighten away potential drug makers.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.